News Headlines Article

OIG Raps CMS Oversight of Compounded Drugs
HealthLeaders Media

More than two years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don’t properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe.

That’s the conclusion of an Office of Inspector General report, which recommends the Centers for Medicare & Medicaid Services consider requiring 55 practices that accreditors should use to oversee compounded sterile preparations (CSPs).